Aflac Incorporated (NYSE:AFL) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS cut its position in Aflac Incorporated (NYSE:AFL) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 106,310 shares of the financial services provider’s stock after selling 3,411 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Aflac were worth $10,997,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Whipplewood Advisors LLC acquired a new position in shares of Aflac in the fourth quarter valued at about $26,000. Darwin Wealth Management LLC acquired a new position in shares of Aflac in the third quarter valued at about $34,000. BankPlus Trust Department acquired a new position in shares of Aflac in the fourth quarter valued at about $34,000. Raelipskie Partnership acquired a new position in shares of Aflac in the third quarter valued at about $38,000. Finally, Curio Wealth LLC acquired a new position in shares of Aflac in the fourth quarter valued at about $36,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Aflac

In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 55,546 shares of company stock valued at $5,863,616 over the last quarter. 0.80% of the stock is currently owned by insiders.

Aflac Price Performance

Shares of Aflac stock opened at $108.10 on Friday. The business has a 50 day simple moving average of $105.95 and a two-hundred day simple moving average of $107.64. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The stock has a market capitalization of $59.08 billion, a P/E ratio of 11.26, a PEG ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on AFL. Evercore ISI lowered their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Morgan Stanley upped their target price on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Barclays lowered their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Piper Sandler lowered their target price on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. Finally, JPMorgan Chase & Co. upped their target price on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Aflac presently has a consensus rating of “Hold” and a consensus target price of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.